首页 > 最新文献

Current Opinion in Ophthalmology最新文献

英文 中文
Reporting outcomes of minimally invasive glaucoma surgery. 报告微创青光眼手术的结果。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-10-28 DOI: 10.1097/ICU.0000000000001100
Naomi E Gutkind, Steven J Gedde

Purpose of review: This review presents guidelines for designing studies and reporting efficacy and safety outcomes in minimally invasive glaucoma surgery (MIGS) research.

Recent findings: Adherence to reporting guidelines in MIGS studies is crucial for providers and patients to appraise surgical options. Recent guidelines have outlined appropriate methodology, efficacy outcomes, and safety reporting, so that study results are presented in an interpretable and uniform manner.

Summary: MIGS are changing the glaucoma treatment paradigm by offering safer, less invasive alternatives to traditional filtering surgery. However, inconsistent reporting of outcomes in MIGS trials hampers comparison and clinical decision-making. Recent guidelines have aimed to highlight appropriate methodology and encourage standardization in reporting outcomes to improve the quality of MIGS literature. Key considerations include defining baseline intraocular pressure, reporting standardized demographic data, using consistent endpoints, presenting standardized figures, evaluating medication use, and documenting adverse events. By adhering to these guidelines, MIGS trials can offer clearer insights into surgical outcomes, aiding both surgeons and patients in treatment decisions.

综述目的:本综述介绍了微创青光眼手术(MIGS)研究中设计研究和报告疗效与安全性结果的指南:遵守微创青光眼手术研究的报告指南对于医疗机构和患者评估手术方案至关重要。摘要:微创青光眼手术为传统滤过手术提供了更安全、创伤更小的替代方案,从而改变了青光眼治疗模式。然而,MIGS 试验结果报告的不一致妨碍了比较和临床决策。近期的指南旨在强调适当的方法并鼓励结果报告的标准化,以提高 MIGS 文献的质量。主要考虑因素包括定义基线眼压、报告标准化的人口统计学数据、使用一致的终点、呈现标准化的数字、评估药物使用情况以及记录不良事件。通过遵守这些准则,MIGS 试验可以更清楚地了解手术效果,帮助外科医生和患者做出治疗决定。
{"title":"Reporting outcomes of minimally invasive glaucoma surgery.","authors":"Naomi E Gutkind, Steven J Gedde","doi":"10.1097/ICU.0000000000001100","DOIUrl":"10.1097/ICU.0000000000001100","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review presents guidelines for designing studies and reporting efficacy and safety outcomes in minimally invasive glaucoma surgery (MIGS) research.</p><p><strong>Recent findings: </strong>Adherence to reporting guidelines in MIGS studies is crucial for providers and patients to appraise surgical options. Recent guidelines have outlined appropriate methodology, efficacy outcomes, and safety reporting, so that study results are presented in an interpretable and uniform manner.</p><p><strong>Summary: </strong>MIGS are changing the glaucoma treatment paradigm by offering safer, less invasive alternatives to traditional filtering surgery. However, inconsistent reporting of outcomes in MIGS trials hampers comparison and clinical decision-making. Recent guidelines have aimed to highlight appropriate methodology and encourage standardization in reporting outcomes to improve the quality of MIGS literature. Key considerations include defining baseline intraocular pressure, reporting standardized demographic data, using consistent endpoints, presenting standardized figures, evaluating medication use, and documenting adverse events. By adhering to these guidelines, MIGS trials can offer clearer insights into surgical outcomes, aiding both surgeons and patients in treatment decisions.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"140-145"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is minimally invasive glaucoma surgery killing trabeculectomies? 微创青光眼手术会杀死小梁切除术吗?
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-13 DOI: 10.1097/ICU.0000000000001108
Seng Chee Loon, Bryan Chin Hou Ang, Andrew White

Purpose of review: The introduction of minimally invasive glaucoma surgery (MIGS) has changed the surgical landscape of glaucoma surgery. For more than four decades, the most commonly performed glaucoma surgery around the world has been the trabeculectomy. This article examines whether trabeculectomy is still the predominant procedure in glaucoma today, in the context of rapidly emerging MIGS devices and procedures.

Recent findings: There is a growing trend of mild to moderate glaucoma cases undergoing MIGS procedures instead of trabeculectomy. Glaucoma drainage device implantation may also have taken away a significant share of the filtering surgery performed for more severe glaucoma. In addition, the availability and economics of implants has an influence on the prevalence of trabeculectomy.

Summary: Currently, trabeculectomy surgery is still the most common glaucoma surgery performed around the world. However, the proportion of glaucoma surgeries undergoing MIGS is increasing rapidly.

综述目的:微创青光眼手术(MIGS)的引入改变了青光眼手术的手术格局。四十多年来,世界上最常见的青光眼手术是小梁切除术。这篇文章探讨了小梁切除术是否仍然是当今青光眼的主要手术,在快速出现的MIGS设备和手术的背景下。最近的发现:越来越多的轻中度青光眼患者选择MIGS手术而不是小梁切除术。青光眼引流装置植入术也可能减少了较为严重的青光眼的滤过手术。此外,植入物的可用性和经济性对小梁切除术的流行率也有影响。摘要:目前,小梁切除术仍然是世界范围内最常见的青光眼手术。然而,青光眼手术采用MIGS的比例正在迅速增加。
{"title":"Is minimally invasive glaucoma surgery killing trabeculectomies?","authors":"Seng Chee Loon, Bryan Chin Hou Ang, Andrew White","doi":"10.1097/ICU.0000000000001108","DOIUrl":"10.1097/ICU.0000000000001108","url":null,"abstract":"<p><strong>Purpose of review: </strong>The introduction of minimally invasive glaucoma surgery (MIGS) has changed the surgical landscape of glaucoma surgery. For more than four decades, the most commonly performed glaucoma surgery around the world has been the trabeculectomy. This article examines whether trabeculectomy is still the predominant procedure in glaucoma today, in the context of rapidly emerging MIGS devices and procedures.</p><p><strong>Recent findings: </strong>There is a growing trend of mild to moderate glaucoma cases undergoing MIGS procedures instead of trabeculectomy. Glaucoma drainage device implantation may also have taken away a significant share of the filtering surgery performed for more severe glaucoma. In addition, the availability and economics of implants has an influence on the prevalence of trabeculectomy.</p><p><strong>Summary: </strong>Currently, trabeculectomy surgery is still the most common glaucoma surgery performed around the world. However, the proportion of glaucoma surgeries undergoing MIGS is increasing rapidly.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"146-151"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive glaucoma surgery in angle closure. 微创青光眼闭角手术。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-18 DOI: 10.1097/ICU.0000000000001117
Nicole Shu-Wen Chan, Chelvin C A Sng

Purpose of review: This review discusses the evidence on the efficacy, safety and role of minimally invasive glaucoma surgery (MIGS) in eyes with angle closure glaucoma. While cataract surgery remains the most established surgical treatment for primary angle closure glaucoma (PACG), the intraocular pressure (IOP) may remain elevated after cataract surgery despite open angles due to trabecular meshwork damage from chronic iridotrabecular contact.

Recent findings: There is emerging evidence that combining cataract surgery with MIGS in eyes with PACG, though an off-label indication for some MIGS devices, can achieve greater IOP and glaucoma medication reduction than cataract surgery alone.

Summary: Trabecular bypass MIGS procedures and less destructive forms of ciliary body treatment have been shown to be effective in PACG and are safer alternatives to traditional incisional surgeries. Evidence for the use of subconjunctival MIGS and suprachoroidal MIGS in angle closure eyes is lacking at present, and further investigation is indicated.

综述目的:本文综述了微创青光眼手术(MIGS)治疗闭角型青光眼的疗效、安全性和作用。虽然白内障手术仍然是原发性闭角型青光眼(PACG)最成熟的手术治疗方法,但由于虹膜小梁接触造成的小梁网损伤,白内障手术后的眼内压(IOP)可能仍然升高,尽管角度开放。最近的发现:越来越多的证据表明,在患有PACG的眼睛中联合白内障手术和MIGS,尽管一些MIGS设备的适应症超出了说明书,但与单独白内障手术相比,可以实现更大的IOP和青光眼药物治疗。摘要:小梁旁路MIGS手术和破坏性较小的睫状体治疗形式已被证明对PACG有效,是传统切口手术更安全的选择。结膜下MIGS和脉络膜上MIGS在闭角眼中的应用目前尚缺乏证据,需要进一步的研究。
{"title":"Minimally invasive glaucoma surgery in angle closure.","authors":"Nicole Shu-Wen Chan, Chelvin C A Sng","doi":"10.1097/ICU.0000000000001117","DOIUrl":"10.1097/ICU.0000000000001117","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review discusses the evidence on the efficacy, safety and role of minimally invasive glaucoma surgery (MIGS) in eyes with angle closure glaucoma. While cataract surgery remains the most established surgical treatment for primary angle closure glaucoma (PACG), the intraocular pressure (IOP) may remain elevated after cataract surgery despite open angles due to trabecular meshwork damage from chronic iridotrabecular contact.</p><p><strong>Recent findings: </strong>There is emerging evidence that combining cataract surgery with MIGS in eyes with PACG, though an off-label indication for some MIGS devices, can achieve greater IOP and glaucoma medication reduction than cataract surgery alone.</p><p><strong>Summary: </strong>Trabecular bypass MIGS procedures and less destructive forms of ciliary body treatment have been shown to be effective in PACG and are safer alternatives to traditional incisional surgeries. Evidence for the use of subconjunctival MIGS and suprachoroidal MIGS in angle closure eyes is lacking at present, and further investigation is indicated.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"152-158"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pearls from glaucoma clinical trials: a case-based approach. 青光眼临床试验的临床珍珠:基于病例的方法。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-20 DOI: 10.1097/ICU.0000000000001113
Laura E Barna, In Young Chung, Lucy Q Shen
{"title":"Clinical pearls from glaucoma clinical trials: a case-based approach.","authors":"Laura E Barna, In Young Chung, Lucy Q Shen","doi":"10.1097/ICU.0000000000001113","DOIUrl":"10.1097/ICU.0000000000001113","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"99-106"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foundation models in ophthalmology: opportunities and challenges. 眼科基础模式:机遇与挑战。
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-04 DOI: 10.1097/ICU.0000000000001091
Mertcan Sevgi, Eden Ruffell, Fares Antaki, Mark A Chia, Pearse A Keane

Purpose of review: Last year marked the development of the first foundation model in ophthalmology, RETFound, setting the stage for generalizable medical artificial intelligence (GMAI) that can adapt to novel tasks. Additionally, rapid advancements in large language model (LLM) technology, including models such as GPT-4 and Gemini, have been tailored for medical specialization and evaluated on clinical scenarios with promising results. This review explores the opportunities and challenges for further advancements in these technologies.

Recent findings: RETFound outperforms traditional deep learning models in specific tasks, even when only fine-tuned on small datasets. Additionally, LMMs like Med-Gemini and Medprompt GPT-4 perform better than out-of-the-box models for ophthalmology tasks. However, there is still a significant deficiency in ophthalmology-specific multimodal models. This gap is primarily due to the substantial computational resources required to train these models and the limitations of high-quality ophthalmology datasets.

Summary: Overall, foundation models in ophthalmology present promising opportunities but face challenges, particularly the need for high-quality, standardized datasets for training and specialization. Although development has primarily focused on large language and vision models, the greatest opportunities lie in advancing large multimodal models, which can more closely mimic the capabilities of clinicians.

回顾的目的:去年,眼科领域开发出首个基础模型 RETFound,为可适应新任务的通用医学人工智能(GMAI)奠定了基础。此外,包括 GPT-4 和 Gemini 等模型在内的大型语言模型(LLM)技术也取得了突飞猛进的发展,这些模型已针对医学专业进行了定制,并在临床场景中进行了评估,取得了可喜的成果。本综述探讨了这些技术进一步发展的机遇和挑战:RETFound 在特定任务中的表现优于传统的深度学习模型,即使仅在小型数据集上进行微调也是如此。此外,Med-Gemini 和 Medprompt GPT-4 等 LMM 在眼科任务中的表现优于开箱即用的模型。然而,眼科专用的多模态模型仍然存在很大的不足。总结:总体而言,眼科基础模型带来了良好的机遇,但也面临着挑战,特别是需要高质量、标准化的数据集来进行训练和专业化。虽然开发工作主要集中在大型语言和视觉模型上,但最大的机遇在于推进大型多模态模型的开发,因为这些模型能更接近临床医生的能力。
{"title":"Foundation models in ophthalmology: opportunities and challenges.","authors":"Mertcan Sevgi, Eden Ruffell, Fares Antaki, Mark A Chia, Pearse A Keane","doi":"10.1097/ICU.0000000000001091","DOIUrl":"10.1097/ICU.0000000000001091","url":null,"abstract":"<p><strong>Purpose of review: </strong>Last year marked the development of the first foundation model in ophthalmology, RETFound, setting the stage for generalizable medical artificial intelligence (GMAI) that can adapt to novel tasks. Additionally, rapid advancements in large language model (LLM) technology, including models such as GPT-4 and Gemini, have been tailored for medical specialization and evaluated on clinical scenarios with promising results. This review explores the opportunities and challenges for further advancements in these technologies.</p><p><strong>Recent findings: </strong>RETFound outperforms traditional deep learning models in specific tasks, even when only fine-tuned on small datasets. Additionally, LMMs like Med-Gemini and Medprompt GPT-4 perform better than out-of-the-box models for ophthalmology tasks. However, there is still a significant deficiency in ophthalmology-specific multimodal models. This gap is primarily due to the substantial computational resources required to train these models and the limitations of high-quality ophthalmology datasets.</p><p><strong>Summary: </strong>Overall, foundation models in ophthalmology present promising opportunities but face challenges, particularly the need for high-quality, standardized datasets for training and specialization. Although development has primarily focused on large language and vision models, the greatest opportunities lie in advancing large multimodal models, which can more closely mimic the capabilities of clinicians.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"90-98"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global prevalence of cataract surgery. 白内障手术的全球患病率。
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-25 DOI: 10.1097/ICU.0000000000001092
Hassan Hashemi, Faezeh Fayaz, Alireza Hashemi, Mehdi Khabazkhoob

Purpose of review: The objective of this review article is to ascertain the global distribution of cataract surgery and evaluate the extent of its coverage in recent years.

Recent findings: The cataract surgical rate (CSR) has been reported from 36 to 12 800 (per million population) across different countries. The average cataract surgical coverage (CSC) in the majority of countries was around 50% or lower. Additionally, in many countries, the efficient CSC (eCSC) deviates from the CSC, emphasizing the importance of attention to the quality of surgical procedures. Socioeconomic status and access to health services are key determinants in the distribution of cataract surgery. This procedure is more prevalent among older individuals, with a higher incidence among men and private insurances tend to cover a larger portion of cataract surgeries. The pandemic of COVID-19 has had a detrimental effect on cataract surgery rates in numerous countries.

Summary: The rate of cataract surgery and its extent of coverage in certain countries is inadequate. The primary factor influencing the quantity and coverage of cataract surgeries is the economic status of the countries. Additionally, government support through insurance and the provision of appropriate healthcare services can contribute to an increase in cataract surgeries.

综述目的:本综述的目的是确定白内障手术的全球分布,并评估近年来白内障手术的覆盖范围。最近的发现:据报道,不同国家的白内障手术率(CSR)从每百万人36例到12800例不等。大多数国家的平均白内障手术覆盖率约为50%或更低。此外,在许多国家,高效CSC (eCSC)偏离了CSC,强调了关注外科手术质量的重要性。社会经济地位和获得保健服务的机会是白内障手术分布的关键决定因素。这种手术在老年人中更为普遍,男性的发病率更高,私人保险往往会支付更多的白内障手术费用。COVID-19大流行对许多国家的白内障手术率产生了不利影响。总结:在某些国家,白内障手术的普及率和覆盖范围都不够。影响白内障手术数量和覆盖率的主要因素是国家的经济状况。此外,政府通过保险和提供适当的保健服务提供的支持有助于白内障手术的增加。
{"title":"Global prevalence of cataract surgery.","authors":"Hassan Hashemi, Faezeh Fayaz, Alireza Hashemi, Mehdi Khabazkhoob","doi":"10.1097/ICU.0000000000001092","DOIUrl":"10.1097/ICU.0000000000001092","url":null,"abstract":"<p><strong>Purpose of review: </strong>The objective of this review article is to ascertain the global distribution of cataract surgery and evaluate the extent of its coverage in recent years.</p><p><strong>Recent findings: </strong>The cataract surgical rate (CSR) has been reported from 36 to 12 800 (per million population) across different countries. The average cataract surgical coverage (CSC) in the majority of countries was around 50% or lower. Additionally, in many countries, the efficient CSC (eCSC) deviates from the CSC, emphasizing the importance of attention to the quality of surgical procedures. Socioeconomic status and access to health services are key determinants in the distribution of cataract surgery. This procedure is more prevalent among older individuals, with a higher incidence among men and private insurances tend to cover a larger portion of cataract surgeries. The pandemic of COVID-19 has had a detrimental effect on cataract surgery rates in numerous countries.</p><p><strong>Summary: </strong>The rate of cataract surgery and its extent of coverage in certain countries is inadequate. The primary factor influencing the quantity and coverage of cataract surgeries is the economic status of the countries. Additionally, government support through insurance and the provision of appropriate healthcare services can contribute to an increase in cataract surgeries.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 1","pages":"10-17"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The global burden of blindness. 失明的全球负担。
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-12-05 DOI: 10.1097/ICU.0000000000001099
Bryanna J Lee, Natalie A Afshari
{"title":"The global burden of blindness.","authors":"Bryanna J Lee, Natalie A Afshari","doi":"10.1097/ICU.0000000000001099","DOIUrl":"10.1097/ICU.0000000000001099","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 1","pages":"1-3"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive update on over the counter artificial tears. 全面更新非处方人工泪液。
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-08 DOI: 10.1097/ICU.0000000000001109
Lilla Simon, Brian A Murillo, Alfonso L Sabater

Purpose of review: Artificial tears play a critical role in the management of dry eye disease (DED), providing patient symptomatic relief and improving ocular surface health. Its clinical importance has driven pharmaceutical innovation in terms of its formula and ingredients. The following article is an overview of the artificial tear products on the market.

Recent findings: The artificial tears on the market vary in terms of their active ingredients, inactive ingredients, preservatives, and formulation. The particular chemical composition of ingredients and formulation plays a clinical role in treating ocular pathology. Conversely, certain ingredients can cause more ocular damage than other ingredients.

Summary: Upon review of the artificial tears on the market, the authors conclude that clinicians should consider the products' composition when designating a treatment for DED. Different artificial tear composition may benefit specific causes of DED such as evaporative, aqueous-deficient, glaucoma, ocular surface tumors, corneal ulcers, and viral conjunctivitis.

综述目的:人工泪液在干眼症(DED)的治疗中发挥着至关重要的作用,可缓解患者症状,改善眼表健康。人工泪液在临床上的重要性推动了药物配方和成分的创新。以下文章概述了市场上的人工泪液产品:市场上的人工泪液在活性成分、非活性成分、防腐剂和配方方面各不相同。成分和配方的特定化学成分在治疗眼部病变方面发挥着临床作用。总结:通过对市场上人工泪液的审查,作者得出结论:临床医生在指定 DED 治疗方法时应考虑产品的成分。不同的人工泪液成分可能对特定原因引起的 DED 有益,如蒸发性 DED、缺水性 DED、青光眼、眼表肿瘤、角膜溃疡和病毒性结膜炎。
{"title":"A comprehensive update on over the counter artificial tears.","authors":"Lilla Simon, Brian A Murillo, Alfonso L Sabater","doi":"10.1097/ICU.0000000000001109","DOIUrl":"10.1097/ICU.0000000000001109","url":null,"abstract":"<p><strong>Purpose of review: </strong>Artificial tears play a critical role in the management of dry eye disease (DED), providing patient symptomatic relief and improving ocular surface health. Its clinical importance has driven pharmaceutical innovation in terms of its formula and ingredients. The following article is an overview of the artificial tear products on the market.</p><p><strong>Recent findings: </strong>The artificial tears on the market vary in terms of their active ingredients, inactive ingredients, preservatives, and formulation. The particular chemical composition of ingredients and formulation plays a clinical role in treating ocular pathology. Conversely, certain ingredients can cause more ocular damage than other ingredients.</p><p><strong>Summary: </strong>Upon review of the artificial tears on the market, the authors conclude that clinicians should consider the products' composition when designating a treatment for DED. Different artificial tear composition may benefit specific causes of DED such as evaporative, aqueous-deficient, glaucoma, ocular surface tumors, corneal ulcers, and viral conjunctivitis.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"76-82"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudophakic cystoid macular edema. 假性囊样黄斑水肿
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-23 DOI: 10.1097/ICU.0000000000001101
Yousef A Fouad, Sam Karimaghaei, Abdelrahman M Elhusseiny, Ahmed R Alagorie, Andrew D Brown, Ahmed B Sallam

Purpose of review: Pseudophakic cystoid macular edema (PCME) is the most common postoperative complication of cataract surgery, resulting in visual decline. In this review, we discuss its pathophysiology, epidemiology, clinical presentation, and the current available evidence on therapeutic management.

Recent findings: Patients with diabetes mellitus have twice the risk of developing PCME as compared to nondiabetic individuals. Recent large database studies have revealed an increased risk among young, male, and black patients. A previous history of PCME is perhaps the strongest risk factor for fellow eye involvement.

Summary: PCME generally occurs around 6 weeks postoperatively and is likely a consequence of postoperative inflammation with disruption of the blood-queous and blood-retina barriers. Optical coherence tomography of the macula servers as a key diagnostic tool. There is a lack of large controlled clinical trials to guide treatment approaches. We recommend a stepwise approach for PCME that includes observation if not visually significant versus treatment with topical nonsteroidal anti-inflammatory drugs and steroids if symptomatic. Refractory cases can be treated with a periocular steroid injection, followed by intravitreal steroids if still nonresponsive.

综述目的:假性囊样黄斑水肿(PCME)是白内障手术最常见的术后并发症,会导致视力下降。在这篇综述中,我们将讨论其病理生理学、流行病学、临床表现以及目前现有的治疗方法:最新发现:与非糖尿病患者相比,糖尿病患者罹患 PCME 的风险是后者的两倍。最近的大型数据库研究显示,年轻、男性和黑人患者患 PCME 的风险更高。总结:PCME 一般发生在术后 6 周左右,可能是术后炎症导致血-水屏障和血-视网膜屏障破坏的结果。黄斑部的光学相干断层扫描是重要的诊断工具。目前还缺乏大型对照临床试验来指导治疗方法。我们建议采用循序渐进的方法治疗 PCME,包括观察(如果没有明显的视觉症状)和局部使用非甾体类抗炎药物和类固醇(如果有症状)。难治性病例可通过眼周注射类固醇进行治疗,如果仍无反应,可在玻璃体内注射类固醇。
{"title":"Pseudophakic cystoid macular edema.","authors":"Yousef A Fouad, Sam Karimaghaei, Abdelrahman M Elhusseiny, Ahmed R Alagorie, Andrew D Brown, Ahmed B Sallam","doi":"10.1097/ICU.0000000000001101","DOIUrl":"10.1097/ICU.0000000000001101","url":null,"abstract":"<p><strong>Purpose of review: </strong>Pseudophakic cystoid macular edema (PCME) is the most common postoperative complication of cataract surgery, resulting in visual decline. In this review, we discuss its pathophysiology, epidemiology, clinical presentation, and the current available evidence on therapeutic management.</p><p><strong>Recent findings: </strong>Patients with diabetes mellitus have twice the risk of developing PCME as compared to nondiabetic individuals. Recent large database studies have revealed an increased risk among young, male, and black patients. A previous history of PCME is perhaps the strongest risk factor for fellow eye involvement.</p><p><strong>Summary: </strong>PCME generally occurs around 6 weeks postoperatively and is likely a consequence of postoperative inflammation with disruption of the blood-queous and blood-retina barriers. Optical coherence tomography of the macula servers as a key diagnostic tool. There is a lack of large controlled clinical trials to guide treatment approaches. We recommend a stepwise approach for PCME that includes observation if not visually significant versus treatment with topical nonsteroidal anti-inflammatory drugs and steroids if symptomatic. Refractory cases can be treated with a periocular steroid injection, followed by intravitreal steroids if still nonresponsive.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"62-69"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How do intraocular lens materials influence the outcome of cataract surgery? 眼内晶体材料如何影响白内障手术的效果?
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-23 DOI: 10.1097/ICU.0000000000001095
Andrzej Grzybowski, Gerd U Auffarth, Benjamin R LaHood

Purpose of review: This review summarizes the evidence on the effect of intraocular lens (IOL) material on the outcomes of cataract surgery, as well as on the surgical procedure itself.

Recent findings: Differences in capsular biocompatibility between IOL materials lead to variations in capsular stability and posterior capsule opacification (PCO), while differences in uveal biocompatibility affect postoperative inflammatory response.

Summary: Refractive outcomes are affected by both incision size and the rotational stability of toric IOLs. Small incision sizes favour hydrophilic IOLs. Rotational stability of hydrophobic and hydrophilic IOLs were comparable in recent studies. Visual outcomes are affected by chromatic aberrations, dysphotopsia, lens opacifications and PCO. Hydrophilic IOLs are associated with reduced chromatic dispersion. Hydrophobic IOL opacifications are caused by sub-surface glistenings, while hydrophilic IOL opacifications are due to surface calcifications. Some surgeries, including pars plana vitrectomy and lamellar corneal transplants, were shown to increase the risk of IOL calcifications, although the mechanism is still unknown. Hydrophilic IOLs have greater ease of manipulation, greater resistance to IOL damage, and higher uveal biocompatibility. Hydrophobic IOLs show better PCO prevention than hydrophilic IOLs, and should be preferred in highly myopic eyes where Nd:YAG capsulotomy might increase the risk of retinal detachment.

综述目的:本综述总结了眼内人工晶体(IOL)材料对白内障手术效果以及手术过程本身影响的证据:不同人工晶体材料的囊内生物相容性差异会导致囊稳定性和后囊不透明(PCO)的变化,而葡萄膜生物相容性的差异会影响术后炎症反应:摘要:屈光结果受切口大小和散光人工晶体旋转稳定性的影响。小切口有利于亲水性人工晶体。在最近的研究中,疏水性和亲水性人工晶体的旋转稳定性相当。视觉效果受色差、视力障碍、晶状体混浊和 PCO 的影响。亲水性人工晶体可减少色散。疏水性人工晶体不透明是由表面下的晶状体造成的,而亲水性人工晶体不透明则是由表面钙化造成的。一些手术,包括玻璃体旁切除术和板层角膜移植术,被证明会增加人工晶体钙化的风险,但其机理尚不清楚。亲水性人工晶体更易于操作,更耐人工晶体损伤,具有更高的葡萄膜生物相容性。疏水性人工晶体比亲水性人工晶体能更好地预防 PCO,对于 Nd:YAG 包囊切开术可能会增加视网膜脱离风险的高度近视眼,疏水性人工晶体是首选。
{"title":"How do intraocular lens materials influence the outcome of cataract surgery?","authors":"Andrzej Grzybowski, Gerd U Auffarth, Benjamin R LaHood","doi":"10.1097/ICU.0000000000001095","DOIUrl":"10.1097/ICU.0000000000001095","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review summarizes the evidence on the effect of intraocular lens (IOL) material on the outcomes of cataract surgery, as well as on the surgical procedure itself.</p><p><strong>Recent findings: </strong>Differences in capsular biocompatibility between IOL materials lead to variations in capsular stability and posterior capsule opacification (PCO), while differences in uveal biocompatibility affect postoperative inflammatory response.</p><p><strong>Summary: </strong>Refractive outcomes are affected by both incision size and the rotational stability of toric IOLs. Small incision sizes favour hydrophilic IOLs. Rotational stability of hydrophobic and hydrophilic IOLs were comparable in recent studies. Visual outcomes are affected by chromatic aberrations, dysphotopsia, lens opacifications and PCO. Hydrophilic IOLs are associated with reduced chromatic dispersion. Hydrophobic IOL opacifications are caused by sub-surface glistenings, while hydrophilic IOL opacifications are due to surface calcifications. Some surgeries, including pars plana vitrectomy and lamellar corneal transplants, were shown to increase the risk of IOL calcifications, although the mechanism is still unknown. Hydrophilic IOLs have greater ease of manipulation, greater resistance to IOL damage, and higher uveal biocompatibility. Hydrophobic IOLs show better PCO prevention than hydrophilic IOLs, and should be preferred in highly myopic eyes where Nd:YAG capsulotomy might increase the risk of retinal detachment.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"18-24"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Ophthalmology
全部 Geobiology Appl. Clay Sci. Geochim. Cosmochim. Acta J. Hydrol. Org. Geochem. Carbon Balance Manage. Contrib. Mineral. Petrol. Int. J. Biometeorol. IZV-PHYS SOLID EART+ J. Atmos. Chem. Acta Oceanolog. Sin. Acta Geophys. ACTA GEOL POL ACTA PETROL SIN ACTA GEOL SIN-ENGL AAPG Bull. Acta Geochimica Adv. Atmos. Sci. Adv. Meteorol. Am. J. Phys. Anthropol. Am. J. Sci. Am. Mineral. Annu. Rev. Earth Planet. Sci. Appl. Geochem. Aquat. Geochem. Ann. Glaciol. Archaeol. Anthropol. Sci. ARCHAEOMETRY ARCT ANTARCT ALP RES Asia-Pac. J. Atmos. Sci. ATMOSPHERE-BASEL Atmos. Res. Aust. J. Earth Sci. Atmos. Chem. Phys. Atmos. Meas. Tech. Basin Res. Big Earth Data BIOGEOSCIENCES Geostand. Geoanal. Res. GEOLOGY Geosci. J. Geochem. J. Geochem. Trans. Geosci. Front. Geol. Ore Deposits Global Biogeochem. Cycles Gondwana Res. Geochem. Int. Geol. J. Geophys. Prospect. Geosci. Model Dev. GEOL BELG GROUNDWATER Hydrogeol. J. Hydrol. Earth Syst. Sci. Hydrol. Processes Int. J. Climatol. Int. J. Earth Sci. Int. Geol. Rev. Int. J. Disaster Risk Reduct. Int. J. Geomech. Int. J. Geog. Inf. Sci. Isl. Arc J. Afr. Earth. Sci. J. Adv. Model. Earth Syst. J APPL METEOROL CLIM J. Atmos. Oceanic Technol. J. Atmos. Sol. Terr. Phys. J. Clim. J. Earth Sci. J. Earth Syst. Sci. J. Environ. Eng. Geophys. J. Geog. Sci. Mineral. Mag. Miner. Deposita Mon. Weather Rev. Nat. Hazards Earth Syst. Sci. Nat. Clim. Change Nat. Geosci. Ocean Dyn. Ocean and Coastal Research npj Clim. Atmos. Sci. Ocean Modell. Ocean Sci. Ore Geol. Rev. OCEAN SCI J Paleontol. J. PALAEOGEOGR PALAEOCL PERIOD MINERAL PETROLOGY+ Phys. Chem. Miner. Polar Sci. Prog. Oceanogr. Quat. Sci. Rev. Q. J. Eng. Geol. Hydrogeol. RADIOCARBON Pure Appl. Geophys. Resour. Geol. Rev. Geophys. Sediment. Geol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1